For the third time in a row, GNH USA attended the Biosimilars Congregation. The 9th Biosimilars Congregation was held on 22nd September 2016 in India.
With top pharmaceutical, biotechnology and regulatory representatives attending the event, the agenda of the conference was to bring world class leaders, delegates and attendees on one platform to share and gain latest information about Biosimilars.
The best minds in the industry discussed the key industry issues with regards to Biosimilars, ranging from the evolving regulatory landscapes, biosimilar guidelines to the legal and economic aspects and current challenges in biosimilar development.
With GNH USA as the Gold Partner for the event, Dr Piyush Gupta (Associate Director, GNH USA) presented his paper on – “Sourcing comparators from RoW (Rest of World) markets with confidence“.
Apart from this, the conference covered the following discussions:
Global biopharma policy & market trends
- The future of biosimilars in India
- The evolving biosimilar sector: Trends and Implications
- Sourcing comparators from RoW (Rest of World) markets with confidence
- Complex biological models in biosimilar development
- Viable extrapolation strategies for biosimilars with special emphasis on TNF antagonists
- Effectively communicate the value of biosimilar products to raise confidence in the class
- Improving characterization of biosimilars with technology
- Create a robust patient services and reimbursement support program for biosimilar products
- The future of the biosimilar industry – mapping the evolution and development of the biosimilar sector
- Forecasting the financial growth of biosimilars in the global healthcare marketplace
- Planning of a biosimilar development project – what to consider from the very beginning
- Clinical development strategies for biosimilars
- Gaining Better Market Access: Is Commercial CMO Acceptable for the Biosimilars Market?
- Regulatory Updates and Development
- Be part of a major networking opportunity
Biosimilars Congregation is an ideal platform for CROs and sponsors to learn the truths / tricks / facts about sourcing comparators from RoW market countries such as India and cut product development costs.
The event was organised by Virtue Insight.
Read the white paper here
Comparator sourcing from Emerging Markets and associated cost savings.
For current service information, see comparator sourcing for clinical trials.